Ahmed Mustafa Rashid
Overview
Explore the profile of Ahmed Mustafa Rashid including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
23
Citations
69
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Dhaliwal J, Hussain F, Ahmed H, Khan A, Khan A, Memon M, et al.
Intern Emerg Med
. 2025 Feb;
PMID: 39979755
Despite therapy advancements, amyloidosis mortality rates for older adults (aged ≥ 65) are rising. This study analyzes trends in amyloidosis-related mortality among older adults in the U.S. We conducted a...
2.
Khan M, Rashid A, Shafi T, Rangaswami J, Cherney D, Butler J
Clin J Am Soc Nephrol
. 2024 Dec;
20(3):451-454.
PMID: 39688924
No abstract available.
3.
Anker M, Rashid A, Butler J, Khan M
Basic Res Cardiol
. 2024 Sep;
120(1):25-34.
PMID: 39311910
Patients with cancer face a significant risk of cardiovascular death, regardless of time since cancer diagnosis. Elderly patients are particularly more susceptible as cancer-associated cardiac complications present in advanced stage...
4.
Siddiqi A, Ali K, Maniya M, Rashid A, Khatri S, Garcia M, et al.
Curr Probl Cardiol
. 2024 Sep;
49(12):102842.
PMID: 39270766
Background: The prevalence of hypertension (HTN) has significantly increased among younger adults (15-45 yrs) in the U.S. Despite this, there is limited data on trends of HTN-related mortality within this...
5.
Fatima K, Malik J, Muskan F, Raza G, Waseem A, Shahid H, et al.
Hum Psychopharmacol
. 2024 Jul;
39(6):e2911.
PMID: 39083548
Objective: Despite the historical neurological use of Withania somnifera, limited evidence supports its efficacy for conditions like anxiety and insomnia. Given its known anti-stress properties, this review evaluated its safety...
6.
Fatima K, Ellahi A, Adil M, Kashif H, Uzair M, Ashraf N, et al.
J Cardiovasc Pharmacol
. 2024 Jul;
85(1):35-43.
PMID: 39027981
Renin-angiotensin system inhibitors (RASis), specifically angiotensin-converting enzyme inhibitors (ACEis) and angiotensin II receptor blockers (ARBs), are widely used antihypertensives. Their impact on the prognostic outcomes among patients with cancer has...
7.
Rashid A, Jamil A, Khan Z, Shakoor M, Kamal U, Khan I, et al.
J Nephrol
. 2024 Jun;
37(7):1833-1841.
PMID: 38916852
Background: Kidney failure ranks as the tenth leading cause of mortality in the United States (US), frequently arising as a complication associated with diabetes mellitus (DM). Methods: Trends in DM...
8.
Khan M, Rashid A, Shafi T, Ferreira J, Butler J
Semin Nephrol
. 2023 Oct;
43(3):151429.
PMID: 37871362
Heart failure (HF), diabetes, and chronic kidney disease (CKD) frequently coexist, with one comorbidity worsening the prognosis of another. β-blockers, angiotensin-receptor-neprilysin inhibitors, renin-angiotensin-aldosterone system inhibitors, mineralocorticoid-receptor antagonists, and sodium-glucose cotransporter-2...
9.
Siddiqi T, Usman M, Rashid A, Javaid S, Ahmed A, Clark 3rd D, et al.
J Am Heart Assoc
. 2023 Jul;
12(14):e029355.
PMID: 37421281
Background To study the prevalence and types of hypertension-mediated organ damage and the prognosis of patients presenting to the emergency department (ED) with hypertensive emergencies. Methods and Results PubMed was...
10.
Fatima K, Asad D, Shaikh N, Ansari S, Kumar G, Rehman H, et al.
Am J Cardiol
. 2023 Jun;
199:85-91.
PMID: 37269781
Mineralocorticoid receptor antagonists (MRAs) are known to improve clinical outcomes in heart failure, particularly heart failure with reduced ejection fraction. However, the effect of MRAs on the incidence of and...